Determinants of small solute clearance in hemodialysis

Seminars in Dialysis

Volumn 18, Issue 1, 2005, Pages 30-35

  Huang, Zhongping ^a   Clark, William R ^b,c,d   Gao, Dayong ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

^b Gambro Renal Products   (United States)

^c INDIANA UNIVERSITY   (United States)

^d WISHARD MEMORIAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

UREA;

ARTIFICIAL KIDNEY; BLOOD COMPONENT; BLOOD FLOW; DENSITY; DIALYSATE; DIALYSIS MEMBRANE; DIFFUSION; ERYTHROCYTE TRANSFUSION; EXTRACORPOREAL CIRCULATION; FLOW RATE; HEMODIALYSIS; HEMODIALYSIS PATIENT; HOSPITALIZATION; HUMAN; KIDNEY FUNCTION; KINETICS; MEASUREMENT; MEMBRANE PERMEABILITY; METABOLISM; MOLECULAR WEIGHT; MORBIDITY; MORTALITY; ORGAN PERFUSION; OUTCOMES RESEARCH; PLASMA CLEARANCE; PRACTICE GUIDELINE; PRESSURE; QUANTITATIVE ANALYSIS; REVIEW; SOLUTE; SURVIVAL; TRANSPORT KINETICS; TREATMENT OUTCOME;

BLOOD UREA NITROGEN; DIALYSIS SOLUTIONS; HUMANS; KIDNEY FAILURE, CHRONIC; RENAL CIRCULATION; RENAL DIALYSIS; UREA;

EID: 14844291613     PISSN: 08940959     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1525-139X.2005.18101.x     Document Type: Review

References (50)

1. Vanholder R, Glorieux G, De Smet R, Lameire N: European Uremic Toxin Work Group: new insights in uremic toxins. Kidney Int Suppl 84:S6-S10, 2003
2. Vanholder R, Vanholder R, De Smet R, Glorieux G, Argiles A, Baurmeister U, Brunet P, Clark W, Cohen G, De Deyn PP, Deppisch R, Descamps-Latscha B, Henle T, Jorres A, Lemke HD, Massy ZA, Passlick-Deetjen J, Rodriguez M, Stegmayr B, Stenvinkel P, Tetta C, Wanner C, Zidek W, European Uremic Toxin Work Group (EUTox): Review on uremic toxins: classification, concentration, and interindividual variability. Kidney Int 63:1934-1943, 2003
3. Clark WR, Gao D: Determinants of uremic toxin removal. Nephrol Dial Transplant 17(suppl 1):1-5, 2002
4. Teschan PE, Ginn HE, Bourne JR, Ward JW, Hamel B, Nunnally JC, Musso M, Vaughn WK: Quantitative indices of clinical uremia. Kidney Int 15:676-697, 1979
5. Lowrie EG, Steinberg SM, Galen MA, Gagneux SA, Lazarus JM, Gottlieb MN, Merrill JP: Factors in the dialysis regimen which contribute to alternations in the abnormalities of uremia. Kidney Int 10:409-422, 1976
6. Lowrie EG, Laird NM, Parker TF, Sargent JA: Effect of the hemodialysis prescription on patient morbidity: report from the National Cooperative Dialysis Study. N Engl J Med 305:1176-1181, 1981
7. Gotch FA, Sargent JA: A mechanistic analysis of the National Cooperative Dialysis Study. Kidney Int 28:526-534, 1985
8. Owen WF, Lew NL, Liu Y, Lowrie EG, Lazarus JM: The urea reduction ratio and serum albumin concentration as predictors of mortality in patients undergoing hemodialysis. N Engl J Med 329:1001-1006, 1993
9. Parker TF, Husni L, Huang W, Lew N, Lowrie EG: Survival of hemodialysis patients in the United States is improved with a greater quantity of dialysis. Am J Kidney Dis 23:67-680, 1994
10. Collins AJ, Ma JZ, Umen A, Keshaviah P: Urea index and other predictors of hemodialysis survival. Am J Kidney Dis 23:272-282, 1994
11. Hakim RM, Breyer J, Ismail N, Schulman G: Effects of dose of dialysis on morbidity and mortality. Am J Kidney Dis 23:661-669, 1994
12. Lowrie EG, Chertow GM, Lew NL, Lazarus JM, Owen WF: The urea [clearance x dialysis time] product (Kt) as an outcome-based measure of hemodialysis dose. Kidney Int 56:729-737, 1999
13. Chertow GM, Owen WF, Lazarus JM, Lew NL, Lowrie EG: Exploring the reverse J-shaped curve between urea reduction ratio and mortality. Kidney Int 56:1872-1878, 1999
14. Eknoyan G, Beck GJ, Cheung AK, Daugirdas JT, Greene T, Kusek JW, Allon M, Bailey J, Delmez JA, Depner TA, Dwyer JT, Levey AS, Levin NW, Milford E, Ornt DB, Rocco MV, Schulman G, Schwab SJ, Teehan BP, Toto R, Hemodialysis (HEMO) Study Group: Effect of dialysis dose and membrane flux in maintenance hemodialysis. N Engl J Med 347:2010-2019, 2002
15. Port FK, Ashby VB, Dhingra RK, Roys EC, Wolfe RA: Dialysis dose and body mass index are strongly associated with survival in hemodialysis patients. J Am Soc Nephrol 13:1061-1066, 2002
16. Paniagua R, Amato D, Vonesh E, Correa-Rotter R, Ramos A, Moran J, Mujais S, Mexican Nephrology Collaborative Study Group: Effects of increased peritoneal clearances on mortality rates in peritoneal dialysis: ADEMEX, a prospective, randomized, controlled trial. J Am Soc Nephrol 13:1307-1320, 2002
17. Ward RA, Leypoldt JK, Clark WR, Ronco C, Mishkin GJ, Paganini EP: What clinically important advances in understanding and improving dialyzer function have occurred recently? Semin Dial 14:160-174, 2001
18. Leypoldt JK, Cheung AK: Optimal use of hemodialyzers. Contrib Nephrol 137:129-137, 2002
19. Ronco C, Brendolan A, Crepaldi C, Rodighiero M, Scabardi M: Blood and dialysate flow distributions in hollow-fiber hemodialyzers analyzed by computerized helical scanning technique. J Am Soc Nephrol 13(suppl 1):S53-S61, 2002
20. Schmidt B, Ward RA: The impact of erythropoietin on hemodialyzer design and performance. Artif Organs 13:35-42, 1989
21. Clark WR, Shinaberger JH: Clinical evaluation of a new high-efficiency hemodialyzer: Polysynthane (PSN™). ASAIO J 46:288-292, 2000
22. Savitz D, Sidel V, Solomon A: Osmotic properties of human red cells. J Gen Physiol 48:79-94, 1964
23. Langsdorf L, Zydney A: Effect of uremia on the membrane transport characteristics of red blood cells. Blood 81:820-827, 1993
24. Cheung A, Alford M, Wilson M, Leypoldt JK, Henderson LW: Urea movement across erythrocyte membrane. Kidney Int 23:866-869, 1983
25. Shinaberger J, Miller J, Gardner P: Erythropoietin alert: risks of high hematocrit hemodialysis. Trans Am Soc Artif Intern Organs 34:179-184, 1988
26. Katz M, Hull A: Transcellular creatinine disequilibrium and its significance in hemodialysis. Nephron 12:171-177, 1974
27. Slatsky M, Schindhelm K, Farrell P: Creatinine transfer between red blood cells and plasma: a comparison between normal and uremic subjects. Nephron 22:514-521, 1978
28. Clark WR, Hamburger RJ, Lysaght MJ: The effect of membrane composition and structure on solute removal and biocompatibility in hemodialysis. Kidney Int 56:2005-2015, 1999
29. Colton C, Smith K, Merrill E, Friedman S: Diffusion of urea in flowing blood. Am Instit Chem Eng J 17:800-808, 1971
30. Lim V, Flanigan M, Fangman J: Effect of hematocrit on solute removal during high efficiency hemodialysis. Kidney Int 37:1557-1562, 1990
31. Zhang J, Parker D, Leypoldt JK: Flow distributions in hollow fiber hemodialyzers using magnetic resonance Fourier velocity imaging. ASAIO J 41:M678-M682, 1995
32. Ronco C, Brendolan A, Crepaldi C, Gastaldon F, Levin NW: Flow distribution and cross filtration in hollow fiber hemodialyzers. Contrib Nephrol 137:120-128, 2002
33. Poh CK, Hardy PA, Liao Z, Huang Z, Clark WR, Gao DY: Effect of flow baffles on the dialysate flow distribution in hollow-fiber hemodialyzers: a non-intrusive experimental study using MRI. J Biomech Eng 125:481-489, 2003
34. Liao Z, Poh CK, Huang Z, Hardy PA, Clark WR, Gao DY: A numerical and experimental investigation of mass transfer in an artificial kidney. J Biomech Eng 125:472-480, 2003
35. Leypoldt JK, Cheung AK, Agodoa LY, Daugirdas JT, Greene T, Keshaviah PR: Hemodialyzer mass transfer-area coefficients for urea increase at high dialysate flow rates. Kidney Int 51:2013-2017, 1997
36. Clark WR, Shinaberger JH: Effect of dialysate-side mass transfer resistance on small solute removal in hemodialysis. Blood Purif 18:260-263, 2000
37. Gastaldon F, Brendolan A, Crepaldi C, Frisone P, Zamboni S, d'Intini V, Poulin S, Hector R, Granziero A, Martins K, Gellert R, Inguaggiato P, Ronco C: Effects of novel manufacturing technology on blood and dialysate flow distribution in a new low flux "alpha polysulfone" hemodialyzer. Int J Artif Organs 26:105-112, 2003
38. Sigdell J, Tersteegen B: Clearance of a dialyzer under varying operating conditions. Artif Organs 10:219-225, 1986
39. Ouseph R, Ward RA: Increasing dialysate flow rate increases dialyzer urea mass transfer-area coefficients during clinical use. Am J Kidney Dis 37:316-320, 2001
40. Hauk M, Kuhlmann M, Riegel W, Kohler H: In vivo effects of dialysate flow rate on Kt/V in maintenance hemodialysis patients. Am J Kidney Dis 35:105-111, 2000
41. Santoro A: Confounding factors in the assessment of delivered hemodialysis dose. Kidney Int Suppl 76:S19-S27, 2000
42. Coyne DW, Delmez J, Spence G, Windus DW: Impaired delivery of hemodialysis prescriptions: An analysis of causes and an approach to evaluation. J Am Soc Nephrol 8:1315-1318, 1997
43. Keshaviah P: Technological aspects of hemodialysis and peritoneal dialysis. In: Nissenson AR, Fine RN, Gentile DE, eds. Clinical Dialysis, 3rd ed. Norwalk, CT: Appleton and Lange, 1995:46-76
44. Bird RB, Stewart WE, Lightfoot EN: Velocity distributions in laminar flow. In: Bird RB, Stewart WE, Lightfoot EN, eds. Transport Phenomena, 1st ed. New York: John Wiley & Sons, 1960:34-70
45. Schneditz D, Daugirdas JT: Compartment effects in hemodialysis. Semin Dial 14:271-277, 2001
46. Popovich R, Hlavinka D, Bomar J, Moncrief J, Decherd J: The consequences of physiological resistances of metabolite removal from the patient-artificial kidney system. Trans Am Soc Artif Intern Organs 21:108-115, 1975
47. Clark WR, Leypoldt JK, Henderson LW, Mueller BA, Scott MK, Vonesh EF: Quantifying the effect of changes in the hemodialysis prescription on effective solute removal with a mathematical model. J Am Soc Nephrol 10:601-610, 1999
48. Pedrini L, Zereik S, Rasmy S: Causes, kinetics, and clinical implications of post-hemodialysis urea rebound. Kidney Int 34:817-824, 1988
49. Daugirdas JT, Schneditz D: Overestimation of hemodialysis dose depends on dialysis efficiency by regional blood flow but not by conventional two pool urea kinetic analysis. ASAIO J 41:M719-M724, 1995
50. Daugirdas JT, Depner TA, Gotch FA, Greene T, Keshaviah P, Levin NW, Schulman G: Comparison of methods to predict equilibrated Kt/V in the HEMO Pilot Study. Kidney Int 52:1395-1405, 1997